SOURCE: Equity Markets Inc.

October 06, 2011 09:00 ET

US Domestic, Global Economic Outlook - Equity Research on Bio-Reference Laboratories, Inc. and Quest Diagnostics Incorporated

MACAU--(Marketwire - Oct 6, 2011) - Today, announced its research report highlighting Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) and Quest Diagnostics Incorporated (NYSE: DGX). Full content and research is available at

Short-term outlooks within US and global economies continue to adjust downward, as US Treasury yields touched their lowest levels in over 65 years. International Monetary Fund downgraded estimates for US growth by 1.0% this year, down from 2.5%. 'Significant downside risks' to the US economy were confirmed by the Federal Reserve pressured by 'strains in global financial markets'.

As the US dollar trades above an eight-month high against the Euro, it highlights a deepening of the Eurozone sovereign debt crisis -- furthered by continued policy inaction from European governments. We expect continued volatility until economic data stabilizes and we see decisive policy action to deal with the Eurozone debt crisis.

Our members are preparing for a turn in tides. Currently, the Credit Suisse Risk Appetite Indicator is at a 30-year low. For the past three occurrences, this level has acted as a leading indicator of large stock market rallies 18 months following.

Equity Markets has reviewed Bio-Reference Laboratories, Inc. for its current position within the healthcare industry. Bio-Reference Laboratories, Inc. (Bio-Reference) is engaged in providing laboratory testing services, to customers in the greater New York metropolitan area, as well as to customers in other states. The full research report on Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) is available here:

Equity Markets has reviewed Quest Diagnostics Incorporated for its development within the healthcare industry. Quest Diagnostics Incorporated is a provider of diagnostic testing, information and services. It offers diagnostic testing services and products to patients, physicians, payers, and others. It offers the United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company owned patient service centers. The full research report on Quest Diagnostics Incorporated (NYSE: DGX) is available here:

About Equity Markets
Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.

Contact Information